Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for trea...

Sector

Healthcare

Industry

Biotechnology

CEO

Sibold, William

Employees

528

Website

www.madrigalpharma.com

IPO Date

2007-02-06

Headquarters

Four Tower Bridge, Suite 200, 200 Barr Harbor Drive, West Conshohocken, Pennsylvania, 19428, United States

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Madrigal Pharmaceuticals MDGL

Madrigal Pharmaceuticals Earnings Call Summary

Madrigal Pharmaceuticals Earnings

Transcripts

Events

About Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals
MDGL